$41.64
+3.94 (+10.44%)
Open$37.02
Previous Close$37.70
Day High$42.50
Day Low$37.02
52W High$46.95
52W Low$14.03
Volume—
Avg Volume33.8K
Market Cap93.50M
P/E Ratio—
EPS$-0.50
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
-53.2% upside
Current
$41.64
$41.64
Target
$19.49
$19.49
$14.75
$19.49 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 29.9K | 28.2K | 2.72M |
| Net Income | -1,390,481 | -1,181,711 | 604.8K |
| Profit Margin | -4,646.1% | -4,413.8% | 22.3% |
| EBITDA | -1,560,923 | -1,400,261 | 831.2K |
| Free Cash Flow | — | — | 485.0K |
| Rev Growth | +5.9% | +5.9% | -5.6% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |